94 related articles for article (PubMed ID: 9878400)
1. The three-dimensional structure of human RNase 4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity.
Terzyan SS; Peracaula R; de Llorens R; Tsushima Y; Yamada H; Seno M; Gomis-Rüth FX; Coll M
J Mol Biol; 1999 Jan; 285(1):205-14. PubMed ID: 9878400
[TBL] [Abstract][Full Text] [Related]
2. A single amino acid substitution changes ribonuclease 4 from a uridine-specific to a cytidine-specific enzyme.
Hofsteenge J; Moldow C; Vicentini AM; Zelenko O; Jarai-Kote Z; Neumann U
Biochemistry; 1998 Jun; 37(26):9250-7. PubMed ID: 9649305
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of substrate specificity in porcine RNase 4.
Liang S; Acharya KR
FEBS J; 2016 Mar; 283(5):912-28. PubMed ID: 26748441
[TBL] [Abstract][Full Text] [Related]
4. Residues 36-42 of liver RNase PL3 contribute to its uridine-preferring substrate specificity. Cloning of the cDNA and site-directed mutagenesis studies.
Vicentini AM; Hemmings BA; Hofsteenge J
Protein Sci; 1994 Mar; 3(3):459-66. PubMed ID: 8019417
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of the ribonuclease MC1 mutants N71T and N71S in complex with 5'-GMP: structural basis for alterations in substrate specificity.
Numata T; Suzuki A; Kakuta Y; Kimura K; Yao M; Tanaka I; Yoshida Y; Ueda T; Kimura M
Biochemistry; 2003 May; 42(18):5270-8. PubMed ID: 12731868
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the ribonuclease MC1 from bitter gourd seeds, complexed with 2'-UMP or 3'-UMP, reveal structural basis for uridine specificity.
Suzuki A; Yao M; Tanaka I; Numata T; Kikukawa S; Yamasaki N; Kimura M
Biochem Biophys Res Commun; 2000 Aug; 275(2):572-6. PubMed ID: 10964705
[TBL] [Abstract][Full Text] [Related]
7. The binding of 3'-N-piperidine-4-carboxyl-3'-deoxy-ara-uridine to ribonuclease A in the crystal.
Leonidas DD; Maiti TK; Samanta A; Dasgupta S; Pathak T; Zographos SE; Oikonomakos NG
Bioorg Med Chem; 2006 Sep; 14(17):6055-64. PubMed ID: 16730994
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of ribonuclease Rh from Rhizopus niveus at 2.0 A resolution.
Kurihara H; Nonaka T; Mitsui Y; Ohgi K; Irie M; Nakamura KT
J Mol Biol; 1996 Jan; 255(2):310-20. PubMed ID: 8551522
[TBL] [Abstract][Full Text] [Related]
9. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional structure of a human pancreatic ribonuclease variant, a step forward in the design of cytotoxic ribonucleases.
Pous J; Canals A; Terzyan SS; Guasch A; Benito A; Ribó M; Vilanova M; Coll M
J Mol Biol; 2000 Oct; 303(1):49-60. PubMed ID: 11021969
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of ribonuclease T1 complexed with an isosteric phosphonate substrate analogue of GpU: alternate substrate binding modes and catalysis.
Arni RK; Watanabe L; Ward RJ; Kreitman RJ; Kumar K; Walz FG
Biochemistry; 1999 Feb; 38(8):2452-61. PubMed ID: 10029539
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic studies on structural features that determine the enzymatic specificity and potency of human angiogenin: Thr44, Thr80, and residues 38-41.
Holloway DE; Chavali GB; Hares MC; Baker MD; Subbarao GV; Shapiro R; Acharya KR
Biochemistry; 2004 Feb; 43(5):1230-41. PubMed ID: 14756559
[TBL] [Abstract][Full Text] [Related]
13. The swapping of terminal arms in ribonucleases: comparison of the solution structure of monomeric bovine seminal and pancreatic ribonucleases.
Avitabile F; Alfano C; Spadaccini R; Crescenzi O; D'Ursi AM; D'Alessio G; Tancredi T; Picone D
Biochemistry; 2003 Jul; 42(29):8704-11. PubMed ID: 12873130
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the structural and functional properties of RNase A and BS-RNase: a stepwise mutagenesis approach.
Ercole C; Colamarino RA; Pizzo E; Fogolari F; Spadaccini R; Picone D
Biopolymers; 2009 Dec; 91(12):1009-17. PubMed ID: 19263489
[TBL] [Abstract][Full Text] [Related]
15. Toward an antitumor form of bovine pancreatic ribonuclease: the crystal structure of three noncovalent dimeric mutants.
Merlino A; Russo Krauss I; Perillo M; Mattia CA; Ercole C; Picone D; Vergara A; Sica F
Biopolymers; 2009 Dec; 91(12):1029-37. PubMed ID: 19280639
[TBL] [Abstract][Full Text] [Related]
16. The amino acid sequence of human ribonuclease 4, a highly conserved ribonuclease that cleaves specifically on the 3' side of uridine.
Zhou HM; Strydom DJ
Eur J Biochem; 1993 Oct; 217(1):401-10. PubMed ID: 8223579
[TBL] [Abstract][Full Text] [Related]
17. Characterization of RNase HII substrate recognition using RNase HII-argonaute chimaeric enzymes from Pyrococcus furiosus.
Kitamura S; Fujishima K; Sato A; Tsuchiya D; Tomita M; Kanai A
Biochem J; 2010 Feb; 426(3):337-44. PubMed ID: 20047562
[TBL] [Abstract][Full Text] [Related]
18. Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth.
Leonidas DD; Shapiro R; Allen SC; Subbarao GV; Veluraja K; Acharya KR
J Mol Biol; 1999 Jan; 285(3):1209-33. PubMed ID: 9918722
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure and structure-based mutational analyses of RNase HIII from Bacillus stearothermophilus: a new type 2 RNase H with TBP-like substrate-binding domain at the N terminus.
Chon H; Matsumura H; Koga Y; Takano K; Kanaya S
J Mol Biol; 2006 Feb; 356(1):165-78. PubMed ID: 16343535
[TBL] [Abstract][Full Text] [Related]
20. Structural determinants of the uridine-preferring specificity of RNase PL3.
Vicentini AM; Kote-Jarai Z; Hofsteenge J
Biochemistry; 1996 Jul; 35(28):9128-32. PubMed ID: 8703917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
